Verona Pharma (VRNA) Insider Trading & Ownership → A new way to collect income from stocks (From DTI) (Ad) Free VRNA Stock Alerts $15.31 +0.07 (+0.46%) (As of 04/25/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Verona Pharma (NASDAQ:VRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.80%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$378,874.24Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$13.41 M Get VRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Verona Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRNA Insider Buying and Selling by Quarter Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Verona Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/20/2023Martin EdwardsDirectorBuy33,736$1.84$62,074.24 11/6/2023David R EbsworthDirectorBuy160,000$1.98$316,800.00 11/3/2023Kathleen A RickardInsiderSell58,752$1.92$112,803.84 8/7/2023Claire PollGeneral CounselSell1,512$2.47$3,734.64 8/7/2023David ZaccardelliCEOSell8,616$2.47$21,281.52 8/7/2023Kathleen A RickardInsiderSell1,600$2.47$3,952.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/4/2023David ZaccardelliCEOSell150,000$2.50$375,000.00 8/3/2023Claire PollGeneral CounselSell20,608$2.54$52,344.32 8/3/2023Kathleen A RickardInsiderSell50,600$2.55$129,030.00 8/3/2023Mark W HahnCFOSell117,272$2.54$297,870.88 8/2/2023David ZaccardelliCEOSell73,704$2.59$190,893.36 8/1/2023Claire PollGeneral CounselSell18,608$2.68$49,869.44 8/1/2023Kathleen A RickardInsiderSell19,736$2.68$52,892.48 8/1/2023Mark W HahnCFOSell105,944$2.68$283,929.92 5/15/2023Orbimed Advisors LlcDirectorSell359,713$20.08$7,223,037.04 5/11/2023Orbimed Advisors LlcDirectorSell80,000$22.26$1,780,800.00 5/3/2023Kathleen A RickardInsiderSell28,752$2.65$76,192.80 5/1/2023Claire PollGeneral CounselSell80,376$2.58$207,370.08 5/1/2023David ZaccardelliCEOSell455,536$2.58$1,175,282.88 5/1/2023Kathleen A RickardInsiderSell77,424$2.58$199,753.92 5/1/2023Mark W HahnCFOSell455,528$2.58$1,175,262.24 (Data available from 1/1/2013 forward) VRNA Insider Trading Activity - Frequently Asked Questions Who is on Verona Pharma's Insider Roster? The list of insiders at Verona Pharma includes Anders Ullman, Claire Poll, David R Ebsworth, David Zaccardelli, Kathleen A Rickard, Lisa Deschamps, Mark W Hahn, Martin Edwards, and Orbimed Advisors Llc. Learn more on insiders at VRNA. What percentage of Verona Pharma stock is owned by insiders? 4.80% of Verona Pharma stock is owned by insiders. Learn more on VRNA's insider holdings. Which Verona Pharma insiders have been buying company stock? The following insiders have purchased VRNA shares in the last 24 months: David R Ebsworth ($316,800.00), and Martin Edwards ($62,074.24). How much insider buying is happening at Verona Pharma? Insiders have purchased a total of 193,736 VRNA shares in the last 24 months for a total of $378,874.24 bought. Which Verona Pharma insiders have been selling company stock? The following insiders have sold VRNA shares in the last 24 months: Claire Poll ($1,352,598.48), David Zaccardelli ($5,232,238.24), Kathleen A Rickard ($839,137.52), Mark W Hahn ($2,830,246.72), and Orbimed Advisors Llc ($95,419,764.96). How much insider selling is happening at Verona Pharma? Insiders have sold a total of 8,810,825 Verona Pharma shares in the last 24 months for a total of $105,673,985.92 sold. More Insider Trading Tools from MarketBeat Related Companies: DAWN Insider Selling PCRX Insider Selling ANIP Insider Selling IRWD Insider Selling KNSA Insider Selling MORF Insider Selling LGND Insider Selling KURA Insider Selling DCPH Insider Selling ZLAB Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:VRNA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.